IDS France SA sets out to conquer the American market

The President of IDS France SA, Alain Rousseau, attests : " IDS-iSYS is a high tech medical automated analyser entirely designed in France, at Poully-en-Auxois, by an extraordinary team. It is dependable, a considerable advantage when commercialising this type of equipment in the immense territory of the USA. It is easy to use, flexible and efficient in its analyses. It allows the easy development of automated tests with a polyvalence never before encountered. Thanks to this type of specialized testing, it is possible to diagnose among others, bone diseases (osteoporosis, rheumatoid arthritis), kidney diseases, cardiovascular diseases, endocrinological diseases, growth-related diseases, high blood pressure…We have managed to manufacture an innovative machine with means at least ten times less than our competitors, major actors in the in vitro diagnostics industry such as Abbott and Roche ! It is a machine which touches many fields : electronics, optics, software, micromechanics, plastics manufacturing, etc. The technical nature requires the invervention of about one hundred suppliers and sub-contractors of which the most strategic are located close-by : in Burgundy, Franche-Comté, the Paris area and in Switzerland".

2010/12/13

ONCODESIGN BIOTECHNOLOGY, leader in oncological therapy assessments

Philippe GENNE, President and CEO, Oncodesign Biotechnology, Dijon “Oncodesign Biotechnology is market leader in the assessment of oncological therapies With over 400 pharmaceutical clients throughout the world, the company makes its contribution to the Pharm’image excellence centre. Unique in France, it is made up of businesses, University hospitals, George –François Leclerc cancer centres and university laboratories. This centre is dedicated to offering Pharma laboratories continuity of skills and research platforms in pharmaco- imaging applied to therapies and to anticancer diagnoses”.

2010/06/22

SANOFI AVENTIS, pharmaceutical industry company

Alain LOUVEL, Production site Director , Sanofi Aventis, Quetigny " The Dijon conurbation is recognised in our sector historically as a pharmaceutical centre With the benefit of 40 years experience, our production site at Quetigny carries out more than 60% of our export business with the support of our 450 associates covering 95 different markets throughout the world. "

2010/05/03

Laboratoires URGO

An endorsement from Etienne Bayle Supply Chain Manager for Laboratoires Urgo at Chevigny-Saint-Sauveur :

“Creating a new site in Burgundy has enabled us to retain employee skills and to bring together in one defined area our research, development and manufacturing and the logistics site. And in addition, the region’s geographic position has been an indisputable advantage for us since we created the company. We are just a day away by lorry from 90% of our French customers. Burgundy logistics operators have their hub in Burgundy and they ensure that we have fast response for our high speed messaging transport and a complete shuttle service to our German subsidiary. "

2010/04/19